Successful treatment of severe psoriasis with basiliximab, an interleukin-2 receptor monoclonal antibody

被引：53

作者：

Owen, CM ^{[1
]}

Harrison, PV ^{[1
]}

机构：

[1] Royal Lancaster Infirm, Dept Dermatol, Lancaster, England

来源：

CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2000年 / 25卷 / 03期

关键词：

D O I：

10.1046/j.1365-2230.2000.00612.x

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

T-cell mediated inflammation plays an important role in the aetiology of psoriasis. We describe a case of severe recalcitrant psoriasis responding well to combined cyclosporin and basiliximab (Simulect((R)) Novartis Pharmaceuticals UK Ltd), an interleukin-2 receptor (IL-2R; CD25) chimeric monoclonal antibody.

引用

页码：195 / 197

页数：3

共 9 条

[1] Administration of DAB389IL-2 to patients with recalcitrant psoriasis:: A double-blind, phase II multicenter trial [J].

Bagel, J ;

Garland, WT ;

Breneman, D ;

Holick, M ;

Littlejohn, TW ;

Crosby, D ;

Faust, H ;

Fivenson, D ;

Nichols, J .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1998, 38 (06) :938-944

[2]

deRie MA, 1996, ACTA DERM-VENEREOL, V76, P357

[3] RESPONSE OF PSORIASIS TO A LYMPHOCYTE-SELECTIVE TOXIN (DAB(389)IL-2) SUGGESTS A PRIMARY IMMUNE, BUT NOT KERATINOCYTE, PATHOGENIC BASIS [J].

GOTTLIEB, SL ;

GILLEAUDEAU, P ;

JOHNSON, R ;

ESTES, L ;

WOODWORTH, TG ;

GOTTLIEB, AB ;

KRUEGER, JG .

NATURE MEDICINE, 1995, 1 (05) :442-447

[4] FLUOXETINE-INDUCED PSORIASIS [J].

HEMLOCK, C ;

ROSENTHAL, JS ;

WINSTON, A .

ANNALS OF PHARMACOTHERAPY, 1992, 26 (02) :211-212

[5] Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts [J].

Kovarik, J ;

Wolf, P ;

Cisterne, JM ;

Mourad, G ;

Lebranchu, Y ;

Lang, P ;

Bourbigot, B ;

Cantarovich, D ;

Girault, D ;

Gerbeau, C ;

Schmidt, AG ;

Soulillou, JP .

TRANSPLANTATION, 1997, 64 (12) :1701-1705

[6] INTERLEUKIN-2 AND PSORIASIS [J].

LEE, RE ;

GASPARI, AA ;

LOTZE, MT ;

CHANG, AE ;

ROSENBERG, SA .

ARCHIVES OF DERMATOLOGY, 1988, 124 (12) :1811-1815

[7] Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients [J].

Nashan, B ;

Moore, R ;

Amlot, P ;

Schmidt, AG ;

Abeywickrama, K ;

Soulillou, JP .

LANCET, 1997, 350 (9086) :1193-1198

[8] THE CYTOKINE NETWORK IN LESIONAL AND LESION-FREE PSORIATIC SKIN IS CHARACTERIZED BY A T-HELPER TYPE-1 CELL-MEDIATED RESPONSE [J].

UYEMURA, K ;

YAMAMURA, M ;

FIVENSON, DF ;

MODLIN, RL ;

NICKOLOFF, BJ .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1993, 101 (05) :701-705

[9] PSORIASIS - A T-CELL-MEDIATED AUTOIMMUNE-DISEASE INDUCED BY STREPTOCOCCAL SUPERANTIGENS [J].

VALDIMARSSON, H ;

BAKER, BS ;

JONSDOTTIR, I ;

POWLES, A ;

FRY, L .

IMMUNOLOGY TODAY, 1995, 16 (03) :145-149

← 1 →